Atrial Fibrillation News and Research

RSS
Atrial fibrillation (AF) is the most common arrhythmia. An arrhythmia is a problem with the speed or rhythm of the heartbeat. A disorder in the heart’s electrical system causes AF and other types of arrhythmia. AF occurs when rapid, disorganized electrical signals in the heart’s two upper chambers, called the atria, cause them to contract very fast and irregularly (this is called fibrillation). As a result, blood pools in the atria and isn’t pumped completely into the heart’s two lower chambers, called the ventricles. When this happens, the heart’s upper and lower chambers don’t work together as they should. Often, people who have AF may not even feel symptoms. However, even when not noticed, AF can lead to an increased risk of stroke. In many patients, particularly when the rhythm is extremely rapid, AF can cause chest pain, heart attack, or heart failure. AF may occur rarely or every now and then, or it may become a persistent or permanent heart rhythm lasting for years.
Janssen announces submission of IMBRUVICA sNDA to FDA for WM treatment

Janssen announces submission of IMBRUVICA sNDA to FDA for WM treatment

Rose Medical Center experts perform LARIAT procedure for patients with atrial fibrillation

Rose Medical Center experts perform LARIAT procedure for patients with atrial fibrillation

High doses of fish oil supplements do not reduce atrial fibrillation

High doses of fish oil supplements do not reduce atrial fibrillation

Blood test can help identify people at increased risk of atrial fibrillation, stroke

Blood test can help identify people at increased risk of atrial fibrillation, stroke

Acutus Medical concludes additional $26.2M financing round to broaden its product portfolio

Acutus Medical concludes additional $26.2M financing round to broaden its product portfolio

Cardiac arrhythmias pose risk in pulmonary hypertension patients

Cardiac arrhythmias pose risk in pulmonary hypertension patients

New AliveECG app provides patients with free real-time AF detection in ECG recordings

New AliveECG app provides patients with free real-time AF detection in ECG recordings

CVRx Barostim neo System receives CE Mark approval from NSAI for treatment of heart failure

CVRx Barostim neo System receives CE Mark approval from NSAI for treatment of heart failure

Enlargement of left atrial appendage may be a risk factor of strokes with cardiac origin: Finnish study

Enlargement of left atrial appendage may be a risk factor of strokes with cardiac origin: Finnish study

New evidence-based guidelines for prevention, treatment of POAF

New evidence-based guidelines for prevention, treatment of POAF

Metabolic abnormalities predict severe hypertension

Metabolic abnormalities predict severe hypertension

Digoxin drug increases risk of adverse cardiovascular events or sudden death

Digoxin drug increases risk of adverse cardiovascular events or sudden death

Simple awareness campaign in general practice helps improve early diagnosis of AF

Simple awareness campaign in general practice helps improve early diagnosis of AF

Permanent atrial fibrillation twins risk of stroke than paroxysmal AF

Permanent atrial fibrillation twins risk of stroke than paroxysmal AF

Morbidity, mortality of AF patients remains high at 1 year even with good use of oral anticoagulants

Morbidity, mortality of AF patients remains high at 1 year even with good use of oral anticoagulants

Plant-based medication after cardiac surgery shows mixed results in reducing complications

Plant-based medication after cardiac surgery shows mixed results in reducing complications

Recommendations on arrhythmia management in ACS patients published in EP Europace

Recommendations on arrhythmia management in ACS patients published in EP Europace

New technology holds potential to identify cardiac disease using video monitoring

New technology holds potential to identify cardiac disease using video monitoring

Janssen, Bayer announce expansion of EXPLORER global cardiovascular research program for XARELTO

Janssen, Bayer announce expansion of EXPLORER global cardiovascular research program for XARELTO

Armetheon raises $7 million in first round of financing

Armetheon raises $7 million in first round of financing

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.